Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

NCT02928497 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

481

Enrollment

INDUSTRY

Sponsor class

Conditions

Stroke

Interventions

DEVICE: WATCHMAN LAAC Device Implant
DRUG: Single Antiplatelet Therapy or No Therapy (Control)

Sponsor

Boston Scientific Corporation